| 摘要 |
One or more probiotic and prebiotic blends are provided that allow survival through the human gastrointestinal (GI) tract and provide desired physiological results. Several embodiments demonstrate that a unique blend of prebiotic with specific probiotic strain blends can survive the GI tract and deliver the physiological effects desired per each blend, for example to treat irritable bowel syndrome (IBS), diarrhea, and constipation. Further, a process is provided to determine in vitro functionality of probiotics and prebiotics for modeling survival in the human or domesticated pet animal GI tract. |
